- Associated Press - Wednesday, November 5, 2014

ALBUQUERQUE, N.M. (AP) - A New Mexico doctor has pleaded guilty in a case in which federal prosecutors accused him of administering misbranded prescription drugs to his cancer patients.

The U.S. Attorney’s Office says Mohamed Basel Aswad entered his plea Tuesday. Under the agreement, he faces up to three years of probation and will have to pay more than $1.2 million in restitution.

Aswad will also be required to forfeit another $750,000.

Under federal law, a prescription drug is misbranded if it’s manufactured in an establishment not registered with the Food and Drug Administration for commercial distribution within the United States. Inadequate directions can also result in a misbranding classification.

Court filings say the drugs administered by Aswad to his patients came from a Canadian company and had instructions written in Turkish.



Sign up for Daily Newsletters

Manage Newsletters

Copyright © 2019 The Washington Times, LLC.

Please read our comment policy before commenting.

 

Click to Read More and View Comments

Click to Hide